OCEA (Ocean Biomedical) Beginning Cash Position: $0.22 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Ocean Biomedical Beginning Cash Position?

Ocean Biomedical OCEA +33.33% Beginning Cash Position is $0.22 Mil as of Mar. 2025.

Ocean Biomedical's Beginning Cash Position for the quarter that ended in Mar. 2025 was $0.22 Mil.

Ocean Biomedical's quarterly Beginning Cash Position increased from Sep. 2024 ($1.13 Mil) to Dec. 2024 ($2.74 Mil) but then declined from Dec. 2024 ($2.74 Mil) to Mar. 2025 ($0.22 Mil).

Ocean Biomedical's annual Beginning Cash Position declined from Dec. 2022 ($2.16 Mil) to Dec. 2023 ($0.03 Mil) but then increased from Dec. 2023 ($0.03 Mil) to Dec. 2024 ($1.00 Mil).

Ocean Biomedical Beginning Cash Position Related Terms

Ocean Biomedical Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Ocean Biomedical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocean Biomedical Beginning Cash Position Chart

Ocean Biomedical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
Get a 7-Day Free Trial 0.00 -0.00 2.16 0.03 1.00

Ocean Biomedical Quarterly Data
Dec19 Mar20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 0.52 1.13 2.74 0.22

Ocean Biomedical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.22 Mil mean?
Ocean Biomedical (OCEA) has a Beginning Cash Position of $0.22 Mil as of Mar. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Ocean Biomedical and its competitors.
Is Ocean Biomedical's Beginning Cash Position too high?
Ocean Biomedical's current Beginning Cash Position is $0.22 Mil.
How does Ocean Biomedical's Beginning Cash Position compare to SIGY and ENDV?
Ocean Biomedical's Beginning Cash Position of $0.22 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Ocean Biomedical and its competitors. Ocean Biomedical's current Beginning Cash Position is $0.22 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ocean Biomedical stock overvalued right now?
Ocean Biomedical (OCEA) has a current Beginning Cash Position of $0.22 Mil. The current Beginning Cash Position is $0.22 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Ocean Biomedical (OCEA), the current Beginning Cash Position is $0.22 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ocean Biomedical Business Description

Address 55 Claverick Street, Room 325, Providence, RI, USA, 02903
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.